From: Scott R. Burger [celltherapy@earthlink.net]
Sent: Friday, June 14, 2002 3:09 PM
To: FDADockets@oc.fda.gov
Cc: ombuds@oc.fda.gov; vasconcells@cber.fda.gov
Subject: Combination Products Containing Live Cellular Components





To whom it may concern:

This is in regard to the Public Hearing scheduled for June 24, on Combination Products Containing Live Cellular Components.  I would like to participate in this public hearing.  My interest is in novel cell, tissue, and gene-based therapies, particularly translational development and GMP production for clinical applications.  

Thank you for your help in this matter.

Sincerely yours,

Scott R. Burger, M.D.
Advanced Cell & Gene Therapy Consulting
105 Highgrove Drive
Chapel Hill, NC 27516
(919) 933-3482 – voice/fax
(919) 414-6947 – mobile
celltherapy@earthlink.net